Rapid and Durable Antiretroviral Effect of the HIV-1 Integrase Inhibitor Raltegravir as Part of Combination Therapy in Treatment-Naive Patients With HIV-1 Infection: Results of a 48-Week Controlled Study.
Markowitz, Martin MD *; Nguyen, Bach-Yen MD +; Gotuzzo, Eduardo MD ++; Mendo, Fernando MD [S]; Ratanasuwan, Winai MD [//]; Kovacs, Colin MD [P]; Prada, Guillermo MD #; Morales-Ramirez, Javier O MD **; Crumpacker, Clyde S MD ++; Isaacs, Robin D MD +; Gilde, Lucinda R BS +; Wan, Hong MS +; Miller, Michael D PhD +; Wenning, Larissa A PhD +; Teppler, Hedy MD +; the Protocol 004 Part II Study Team
JAIDS Journal of Acquired Immune Deficiency Syndromes.
46(2):125-133, October 1, 2007.
(Format: HTML, PDF)